Indiana is set to receive $6.25 million through a settlement with several global pharmaceutical companies accused of working together to drive up the price of EpiPen by more than 600% for customers.

Read Full Story: https://news.google.com/rss/articles/CBMiakFVX3lxTFBYN1JQenVzak8tVm1xeXNyS3FV...